FNY Investment Advisers’s Genocea Biosciences, Inc. GNCA Stock Holding History

FNY Investment Advisers’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-190,000	Closed	-$514K	–	1097
2021 Q1	$514K	Sell	190,000 -10,000	-5%	-$29.6K	0.19%	101
2020 Q4	$484K	Hold	200,000	–	–	0.13%	138
2020 Q3	$458K	Sell	200,000 -100,000	-33%	-$262K	0.19%	112
2020 Q2	$690K	Hold	300,000	–	–	0.4%	64
2020 Q1	$516K	Buy	300,000 +25,000	+9%	+$50.5K	0.39%	61
2019 Q4	$569K	Buy	275,000 +22,000	+9%	+$52.2K	0.18%	89
2019 Q3	$733K	Buy	253,000 +118,600	+88%	+$405K	0.22%	61
2019 Q2	$526K	Buy	+134,400	New	+$701K	0.16%	83

Other funds holding GNCA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

FNY Investment Advisers's GNCA Position: Q2 2021 in Review

FNY Investment Advisers sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2021, closing a stake of 190,000 shares — an estimated $514K sold.

FNY Investment Advisers first reported a position in GNCA in Q2 2019 and held it in 8 quarters. The position peaked at $733K in Q3 2019. 46 funds tracked by Wall St. Rank hold GNCA as of Q2 2021.

FNY Investment Advisers reported no remaining Genocea Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
FNY Investment Advisers sold 190,000 Genocea Biosciences, Inc. shares in Q2 2021, an estimated $514K.
FNY Investment Advisers first reported a position in Genocea Biosciences, Inc. in Q2 2019 and held it in 8 quarters.
FNY Investment Advisers's Genocea Biosciences, Inc. position peaked at $733K in Q3 2019.
46 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2021.

Based on FNY Investment Advisers's 13F filing for Q2 2021, filed 14 Jul 2021.